HOME >> BIOLOGY >> NEWS
Achillion and UMBC collaboration identifies new class of agents with potential to treat HIV

Baltimore, MD and New Haven, CT, April 1, 2003 In a successful partnership between industry and academia, researchers from The University of Maryland, Baltimore County (UMBC) and Achillion Pharmaceuticals today announced the discovery of a new target on the HIV molecule that could potentially lead to a new class of anti-viral drugs to fight the virus that causes AIDS. The study, headed by Dr. Michael Summers, UMBC professor of chemistry/biochemistry and Howard Hughes Medical Institute (HHMI) Investigator, is featured on the cover of this week's Journal of Molecular Biology.

"The greatest challenge in treating HIV today is drug resistance brought on when the virus mutates and renders existing drugs ineffective at stopping viral replication," said Dr. Summers. "Our research has led to the identification of a new class of compounds that inhibit a novel target in HIV. These compounds disrupt the assembly of the HIV-1 capsid protein, which is a vital step in changing immature, non-infectious HIV into its mature, infectious form."

"Investigators around the world have been looking at the HIV-1 capsid protein as a potential drug target for more than a decade, and we are therefore particularly pleased to finally have solid leads to guide these efforts," said William G. Rice, Ph.D., Achillion's CEO. "While we are encouraged by the laboratory tests of the compounds we've identified so far, additional testing needs to be undertaken before this approach can be tested in humans."

Dr. Summers and his team identified the target at the UMBC HHMI Lab and discovered a number of compounds that bound to a specific area of the capsid protein thought to play a key role in the assembly process necessary for HIV to mature to its infectious form. The identification process leveraged the nuclear magnetic resonance (NMR) technology resources and target validation expertise at Summers' HHMI laboratory.

Once the new capsid assembly target and compounds inhibitin
'"/>

Contact: Amy Enders
aenders@achillion.com
203-401-3135
Achillion Pharmaceuticals
1-Apr-2003


Page: 1 2

Related biology news :

1. North Shore-LIJ research collaboration with Correlogic Systems to advance ovarian cancer blood test
2. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
3. Institute for Systems Biology, Pacific Northwest National Laboratory announce collaboration
4. NCI awards $7.6 million to prostate cancer research collaboration
5. Research collaboration identifies gene essential to puberty
6. Scripps team part of collaboration that reveals first ecological genomic blueprints
7. US-EC Biotech Task Force keys on research, collaboration
8. JGI and Diversa Corp. announce large-scale microbial sequencing collaboration
9. Web-based collaboration links labs to supercomputers
10. UC & sister institutions form Institute Without Walls for transdisciplinary collaborations
11. Citing human obligation, AAAS CEO urges U.S.-Cuban collaboration

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that the company has received ISO9001:2015 certification for the development ... research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell biotechnology ... the stem cell medicine and pharmaceutical industries have easier access to stem cell counting, ... July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering ...
(Date:6/11/2020)... SEABROOK, N.H. (PRWEB) , ... June 09, 2020 , ... ... integrator of custom industrial automation and IT solutions for the life sciences industry, is ... President of Business Development working out of the company’s Seabrook, New Hampshire office. ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... The Indoor ... launch of Safe Space™ for businesses of all types to ensure cleanliness, distancing and ... , A Safe Space™ enabled business will provide a health performance index ...
(Date:6/23/2020)... Fla. (PRWEB) , ... June 23, 2020 , ... ... enabled solutions in complex indoor environments, announced today that Derek Fournier has been ... role of Chairman of the Board, effective immediately. , “DeCurtis Corporation has ...
(Date:6/11/2020)... HOUSTON (PRWEB) , ... June 08, 2020 , ... ... first universal vaccine platform delivered through the use of proprietary clean viral vectors, ... vaccine in the United States. Greffex’s platform is the world’s most successful ...
(Date:6/2/2020)... , ... June 01, 2020 , ... ... to companies and encourage positive change in the world, enterprise security solutions provider ... , With more people working from home during self-quarantines and shelter-in-place orders, companies ...
Breaking Biology Technology:
Cached News: